A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Clinical trial NCT06887192 · RECRUITING
Trial details
- NCT number
- NCT06887192
- Sponsor
- MapLight Therapeutics
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-15
- Primary completion
- 2027-12-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.